Is the cost of monitoring employees at home worth the erosion of trust?

Is the cost of monitoring employees at home worth the erosion of trust?

Continue reading →

Trials of a vaccine and a new drug raise hopes of beating Covid-19

Trials of a vaccine and a new drug raise hopes of beating Covid-19

Oxford University published a paper in the Lancet on their trial of a Covid-19 vaccine on the 20th of July 2020. Even though Oxford University has been researching a vaccine since January 2020 and AstraZeneca (AZN.L) rushed to get...

Continue reading →

Trump’s 4 Exec Orders to lower drugs prices and save $17bn – not what it seems

Trump’s 4 Exec Orders to lower drugs prices and save $17bn – not what it seems

US President Trump signed four executive orders on the 24th July 2020 aimed at lowering drug prices and setting an International Price Index (IPI) for drugs. While the Covid-19 pandemic has muted calls for drug price reductions over the...

Continue reading →

Behavioural health coding double-accounted for in US official reports

Behavioural health coding double-accounted for in US official reports

In a University of Minnesota School of Public Health (SPH) recent publication in the American Journal of Public Health, it was reported that the US federal public health expenditure has been overestimated by at least 2x. In 2019, the US...

Continue reading →

What can ants and bees teach us about containing disease

What can ants and bees teach us about containing disease

Nathalie Stroeymeyt, a senior lecturer in the School of Biological Sciences at the University of Bristol, drew parallels from the guides to social distancing during the Covid-19 pandemic and how ants behave in a recent research study. The research was...

Continue reading →

Europeans aren’t really using Covid-19 contact-tracing apps

Europeans aren’t really using Covid-19 contact-tracing apps

12 out of the 28 European countries have released Covid-19 tracing apps in June 2020, however it seems that no one is using them.   Exhibit 1 - EU Covid-19 Tracing app usage Source: ACF Equity Research, VICE Germany's Corona-Warn app is only...

Continue reading →

Horseshoe crab blood is key to making a Covid-19 vaccine – but the ecosystem may suffer

Horseshoe crab blood is key to making a Covid-19 vaccine – but the ecosystem may suffer

In 2016 a synthetic alternative (rFC) to horseshoe crab blood, used in bacterial infection detection for injectable procedures, was licensed. And yet horseshoe crabs are both threatened with extinction and in line for preservation due to Covid-19 and its...

Continue reading →

How will the rise of biosimilars impact biologics

How will the rise of biosimilars impact biologics

● Once patents expire for biologic medicines, a market opportunity opens up for biosimilars, a cheaper alternative. Biosimilars were mainly brought in to thwart the monopoly power of biologics in the pharmaceutical industry. ● Biosimilars are expected to increase at...

Continue reading →

Competition lowers drug prices, FDA says

Competition lowers drug prices, FDA says

According to a report by the US Food and Drug Administration (FDA), increased generic drug entry will lead to price reductions in the market (see our table below) as well as huge savings opportunities for patients, or at least...

Continue reading →

Doctors may be missing illnesses because UK medical textbooks often focus on white people

Doctors may be missing illnesses because UK medical textbooks often focus on white people

Malone Mukwende, a medical student from St. George's, University of London noticed during his studies that there was a problem with Ethnic Dermatology. Mr Mukwende's observation leads us to wider questions over healthcare investment opportunities, telemedicine, remote patient monitoring,...

Continue reading →